Governments in both developed and developing countries are pushing for cost-cutting measures including decreasing prescription reimbursement rates and encouraging the use of generics. Government agencies, insurers, and patients all put great pressure on pharmaceutical medication delivery systems to minimise costs. Lower pricing pressure leads to improved pharmaceutical acceptability in emerging nations, where low-cost medicines are in high demand.
This, on the other hand, has a negative impact on the profitability of certainmethods. This trend is expected to continue in the coming years as insurers, pharmacy benefit managers (PBMs), and public and private payers push for improved pharmaceutical dosage forms and drug delivery systems in response to concerns about covering more new medicines to treat common conditions like high cholesterol and diabetes.
Explore the Complete Study- https://bit.ly/3N2ZFcj